Continue to site >
Trending ETFs

EMERGING MARKETS GROWTH FUND INC

mutual fund
EMGEX
Payout Change
Pending
Price as of:
$6.93 +0.02 +0.29%
primary theme
Emerging Markets Equity
EMGEX (Mutual Fund)

EMERGING MARKETS GROWTH FUND INC

Payout Change
Pending
Price as of:
$6.93 +0.02 +0.29%
primary theme
Emerging Markets Equity
EMGEX (Mutual Fund)

EMERGING MARKETS GROWTH FUND INC

Payout Change
Pending
Price as of:
$6.93 +0.02 +0.29%
primary theme
Emerging Markets Equity

Name

As of 12/04/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$6.93

$1.31 B

1.41%

$0.10

0.74%

Vitals

YTD Return

5.0%

1 yr return

9.2%

3 Yr Avg Return

-5.0%

5 Yr Avg Return

1.8%

Net Assets

$1.31 B

Holdings in Top 10

30.4%

52 WEEK LOW AND HIGH

$6.9
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 0.74%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 35.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$1,000,000

IRA

N/A


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 12/04/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$6.93

$1.31 B

1.41%

$0.10

0.74%

EMGEX - Profile

Distributions

  • YTD Total Return 5.0%
  • 3 Yr Annualized Total Return -5.0%
  • 5 Yr Annualized Total Return 1.8%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 1.06%
DIVIDENDS
  • Dividend Yield 1.4%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    EMERGING MARKETS GROWTH FUND INC
  • Fund Family Name
    Capital Group Fund Group
  • Inception Date
    May 30, 1986
  • Shares Outstanding
    N/A
  • Share Class
    F3
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Victor Kohn

Fund Description

The fund invests primarily in common stock and other equity securities of issuers in developing countries. Developing countries are also known as “emerging markets.” In determining whether an issuer is in a developing country, the fund will consider, among other things, whether the country is generally considered to be a developing country by the international financial community, where the issuer is domiciled and/or the location of the issuer’s principal place of business. Equity securities are securities that exhibit ownership characteristics, including common and preferred stock, securities convertible into common and preferred stock and depository receipts representing ownership in common and preferred stock. Under normal market conditions, the fund invests at least 90% of its net assets in developing country equity securities. These securities are discussed more fully under “Investment objective, strategies and risks.”

The fund may have significant exposure to one or more developing countries. For example, as of December 31, 2023, the fund held more than 30% of its assets in securities of issuers domiciled in China. See the paragraphs captioned “Investing outside the United States,” “Investing in developing countries” and “Exposure to country, region, industry or sector” under “Principal risks” below for a description of risks associated with such investments. More current portfolio holdings information for the fund is available on our website at capitalgroup.com.

The investment adviser uses a system of multiple portfolio managers in managing the fund’s assets. Under this approach, the portfolio of the fund is divided into segments managed by individual managers.

The fund relies on the professional judgment of its investment adviser to make decisions about the fund’s portfolio investments. The basic investment philosophy of the investment adviser is to seek to invest in attractively valued companies that, in its opinion, represent good, long-term investment opportunities. Securities may be sold when the investment adviser believes that they no longer represent relatively attractive investment opportunities.

Read More

EMGEX - Performance

Return Ranking - Trailing

Period EMGEX Return Category Return Low Category Return High Rank in Category (%)
YTD 5.0% -11.8% 37.0% 80.31%
1 Yr 9.2% -8.2% 39.5% 85.59%
3 Yr -5.0%* -11.0% 11.8% 78.14%
5 Yr 1.8%* -5.1% 12.1% 68.20%
10 Yr N/A* -1.8% 6.6% 66.20%

* Annualized

Return Ranking - Calendar

Period EMGEX Return Category Return Low Category Return High Rank in Category (%)
2023 6.6% -6.5% 35.5% 69.18%
2022 -25.8% -50.1% -2.4% 64.37%
2021 -11.0% -33.1% 22.5% 73.91%
2020 13.7% -22.1% 80.1% 62.34%
2019 17.0% -0.7% 42.0% 56.30%

Total Return Ranking - Trailing

Period EMGEX Return Category Return Low Category Return High Rank in Category (%)
YTD 5.0% -11.8% 37.0% 80.31%
1 Yr 9.2% -8.2% 39.5% 85.59%
3 Yr -5.0%* -11.0% 11.8% 78.14%
5 Yr 1.8%* -5.1% 12.1% 68.20%
10 Yr N/A* -1.8% 6.6% 65.05%

* Annualized

Total Return Ranking - Calendar

Period EMGEX Return Category Return Low Category Return High Rank in Category (%)
2023 8.2% -1.0% 42.0% 74.72%
2022 -24.8% -42.2% 1.9% 67.01%
2021 -0.9% -32.5% 33.1% 48.91%
2020 21.5% -20.0% 81.6% 37.99%
2019 24.0% 2.3% 42.0% 30.25%

NAV & Total Return History


EMGEX - Holdings

Concentration Analysis

EMGEX Category Low Category High EMGEX % Rank
Net Assets 1.31 B 682 K 103 B 32.91%
Number of Holdings 131 2 7534 36.45%
Net Assets in Top 10 424 M 290 K 23.8 B 34.33%
Weighting of Top 10 30.36% 2.9% 101.1% 65.20%

Top 10 Holdings

  1. TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 8.30%
  2. TENCENT HOLDINGS LTD 4.55%
  3. INNOVENT BIOLOGICS INC 2.80%
  4. CAPITAL GROUP CENTRAL CASH FUND 2.72%
  5. NETEASE INC 2.28%
  6. BEIGENE LTD ADR 2.09%
  7. PT BANK SYARIAH INDONESIA TBK 1.96%
  8. SHENZHEN INOVANCE TECHNOLOGY CO LTD A (SZSE NORTH) 1.92%
  9. SAMSUNG ELECTRONICS CO LTD 1.91%
  10. JIANGSU HENGRUI MEDICINE CO LTD A (SSE NORTH) 1.83%

Asset Allocation

Weighting Return Low Return High EMGEX % Rank
Stocks
97.75% 0.00% 103.28% 45.25%
Cash
2.72% -2.03% 100.35% 31.06%
Preferred Stocks
0.00% 0.00% 13.31% 61.70%
Other
0.00% -1.11% 39.53% 36.60%
Convertible Bonds
0.00% 0.00% 7.40% 12.71%
Bonds
0.00% 0.00% 95.13% 20.85%

Stock Sector Breakdown

Weighting Return Low Return High EMGEX % Rank
Financial Services
23.03% 0.00% 48.86% 38.65%
Technology
16.48% 0.00% 47.50% 87.21%
Healthcare
15.93% 0.00% 16.53% 0.57%
Communication Services
11.82% 0.00% 39.29% 16.38%
Consumer Cyclical
11.64% 0.00% 48.94% 53.74%
Industrials
6.87% 0.00% 43.53% 36.64%
Basic Materials
5.69% 0.00% 30.03% 71.26%
Consumer Defense
5.12% 0.00% 25.90% 70.40%
Energy
1.34% 0.00% 24.80% 82.76%
Real Estate
1.23% 0.00% 17.15% 61.93%
Utilities
0.85% 0.00% 39.12% 60.49%

Stock Geographic Breakdown

Weighting Return Low Return High EMGEX % Rank
Non US
82.11% 0.00% 100.52% 63.69%
US
15.63% 0.00% 100.95% 28.65%

EMGEX - Expenses

Operational Fees

EMGEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.74% 0.03% 29.98% 86.06%
Management Fee 0.62% 0.00% 2.00% 16.05%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.01% 0.85% N/A

Sales Fees

EMGEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

EMGEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

EMGEX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 35.00% 0.00% 189.00% 33.92%

EMGEX - Distributions

Dividend Yield Analysis

EMGEX Category Low Category High EMGEX % Rank
Dividend Yield 1.41% 0.00% 9.74% 61.84%

Dividend Distribution Analysis

EMGEX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annual Quarterly Annual

Net Income Ratio Analysis

EMGEX Category Low Category High EMGEX % Rank
Net Income Ratio 1.06% -1.98% 17.62% 38.59%

Capital Gain Distribution Analysis

EMGEX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually Annually

Distributions History

View More +

EMGEX - Fund Manager Analysis

Managers

Victor Kohn


Start Date

Tenure

Tenure Rank

Sep 01, 1994

27.76

27.8%

Victor D. Kohn is an equity portfolio manager at Capital Group. He is president of Capital International, Inc. He has 37 years of investment experience and has been with Capital Group for 36 years. Earlier in his career, as an equity investment analyst at Capital, Victor covered Chile, Argentina and Brazil. Prior to joining Capital, Victor was an analyst in the venture capital group at Montgomery Securities.

F. Chapman Taylor


Start Date

Tenure

Tenure Rank

Jul 01, 2016

5.92

5.9%

F. Chapman Taylor is an equity portfolio manager at Capital Group. As an equity investment analyst at Capital, he covers Asian telecom companies excluding Japan, as well as companies domiciled in Indonesia, the Philippines and New Zealand. He has 28 years of investment experience and has been with Capital Group for 25 years. Before joining Capital, he worked as a consultant with SRI International and Strategic Planning Associates, advising ASEAN, U.S. and U.K. companies on business strategy. He holds an MBA in finance and strategic planning from the Wharton School of the University of Pennsylvania, and a bachelor’s degree in physics and theology from Tulane University. Chapman is based in Washington, D.C.

Eu-Gene Cheah


Start Date

Tenure

Tenure Rank

Jun 01, 2019

3.0

3.0%

Eu-Gene Cheah is an equity portfolio manager at Capital Group. He has 24 years of investment experience, all with Capital Group. Earlier in his career at Capital, he was an equity investment analyst covering pharmaceutical and biotechnology companies globally. He was also a country analyst for Singapore. Before joining Capital, Eu-Gene was a physician in the UK, where he was a Member of the Royal College of Physicians and a Fellow of the Royal College of Ophthalmologists.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.09 33.71 6.67 13.42